Regeneron Pharmaceuticals (REGN) was range-bound for the bulk of Wednesday's session, but climbed steadily in the final 90 minutes of the afternoon. The stock finished higher by $0.65 at $28.65.
Regeneron Pharmaceuticals has been rising for the past 2 weeks and closed Wednesday at its second consecutive new high for the year.
For comments and feedback: editorial@rttnews.com